[1]
|
International Diabetes Federation (2019) Diabetes Atlas 9th Edition. https://diabetesatlas.org/en/
|
[2]
|
Gabr, M.M., Za-karia, M.M., Refaie, A.F., Khater, S.M., Ashamallah, S.A., Ismail, A.M., et al. (2015) Differentiation of Human Bone Marrow-Derived Mesenchymal Stem Cells into Insulin-Producing Cells: Evidence for Further Maturation in Vivo. Bio-Med Research International, 2015, Article ID: 575837. https://doi.org/10.1155/2015/575837
|
[3]
|
Hayashi, T., Takai S. and Yamashita, C. (2010) Impact of the Renin-Angiotensin-Aldosterone-System on Cardiovascular and Renal Complications in Diabetes Mellitus. Current Vascular Pharmacology, 8, 189-197.
https://doi.org/10.2174/157016110790886947
|
[4]
|
Vargas, S.L., Toma, I., Kang, J.J., Meer, E.J. and Peti-Peterdi, J. (2009) Activation of the Succinate Receptor GPR91 in Macula Densa Cells Causes Renin Release. Journal of the American Society of Nephrology, 20, 1002-1011.
https://doi.org/10.1681/ASN.2008070740
|
[5]
|
Wolf, G., Mueller, E., Stahl, R.A. and Ziyadeh, F.N. (1993) Angi-otensin II-Induced Hypertrophy of Cultured Murine Proximal Tubular Cells Is Mediated by Endogenous Transforming Growth Factor-Beta. Journal of Clinical Investigation, 92, 1366-1372. https://doi.org/10.1172/JCI116710
|
[6]
|
Ka-linyak, J.E., Sechi, L.A., Griffin, C.A., Don, B.R., Tavangar, K., Kraemer, F.B., et al. (1993) The Renin-Angiotensin System in Streptozotocin-Induced Diabetes Mellitus in the Rat. Journal of the American Society of Nephrology, 4, 1337-1345.
|
[7]
|
Tesch, G.H., (2008) MCP-1/CCL2: A New Diagnostic Marker and Therapeutic Target for Progressive Renal Injury in Diabetic Nephropathy. American Journal of Physiology-Renal Physiology, 294, F697-F701.
https://doi.org/10.1152/ajprenal.00016.2008
|
[8]
|
Wada, T., Yokoyama, H., Matsushima, K. and Kobayashi, K. (2003) Monocyte Chemoattractant Protein-1: Does It Play a Role in Diabetic Nephropathy? Nephrology Dialysis Trans-plantation, 18, 457-459.
https://doi.org/10.1093/ndt/18.3.457
|
[9]
|
Yadav, A., Vallabu, S., Arora, S., Tandon, P., Slahan, D., Teichberg, S., et al. (2010) ANG II Promotes Autophagy in Podocytes. American Journal of Physiology-Cell Physiology, 299, C488-C496.
https://doi.org/10.1152/ajpcell.00424.2009
|
[10]
|
Sun, L. and Kanwar, Y.S. (2015) Relevance of TNF-Alpha in the Context of Other Inflammatory Cytokines in the Progression of Diabetic Nephropathy. Kidney International, 88, 662-665. https://doi.org/10.1038/ki.2015.250
|
[11]
|
Di Paolo, S., Gesualdo, L, Ranieri, E, Grandaliano, G, Schena, F.P. (1996) High Glucose Concentration Induces the Overexpression of Transforming Growth Factor-Beta through the Acti-vation of a Platelet-Derived Growth Factor Loop in Human Mesangial Cells. The American Journal of Pathology, 149, 2095-2106.
|
[12]
|
Noh, H. and King, G.L. (2007) The Role of Protein Kinase C Activation in Diabetic Nephropathy. Kidney International, 2007, S49-S53. https://doi.org/10.1038/sj.ki.5002386
|
[13]
|
Derubertis, F.R. and Craven, P.A. (1994) Activation of Protein Kinase C in Glomerular Cells in Diabetes. Mechanisms and Potential Links to the Patho-genesis of Diabetic Glomerulopathy. Diabetes, 43, 1-8.
https://doi.org/10.2337/diab.43.1.1
|
[14]
|
Rodriguez-Iturbe, B., Pons, H., Herrera-Acosta, J. and Johnson, R.J. (2001) Role of Immunocompotent Cells in Nonimmune Renal Diseases. Kidney International, 59, 1626-1640.
https://doi.org/10.1046/j.1523-1755.2001.0590051626.x
|
[15]
|
Griffin, M.D., Elliman, S.J., Cahill, E., English, K., Ceredig, R. and Ritter, T. (2013) Concise Review: Adult mesenchymal stromal Cell Therapy for Inflammatory Diseases: How Well Are We Joining the Dots? Stem Cells, 31, 2033-2041.
https://doi.org/10.1002/stem.1452
|
[16]
|
Li, H., Rong, P.F., Ma, X.Q., Nie, W., Chen, Y., Zhang, J., et al. (2020) Mouse Umbilical Cord Mesenchymal Stem Cell Paracrine Alleviates Renal Fibrosis in Diabetic Nephropathy by Reduc-ing Myofibroblast Transdifferentiation and Cell Proliferation and Upregulating MMPs in Mesangial Cells. Journal of Diabetes Research, 2020, Article ID: 3847171.
https://doi.org/10.1155/2020/3847171
|
[17]
|
Xiang, E., et al. (2020) Human Umbilical Cord-Derived Mesenchymal Stem Cells Prevent the Progression of Early Diabetic Nephropathy through Inhibiting Inflammation and Fibrosis. Stem Cell Research & Therapy, 11, 336.
|
[18]
|
Herrera, M.B., Bussolati, B., Bruno, S., Fonsato, V., Romanazzi, G.M. and Camussi, G. (2004) Mesenchymal Stem Cells Contribute to the Renal Repair of Acute Tubular Epithelial Injury. Interna-tional Journal of Molecular Medicine, 14, 1035-1041. https://doi.org/10.3892/ijmm.14.6.1035
|
[19]
|
Gili, M., Orsello, A., Gallo, S. and Brizzi, M.F. (2013) Diabetes-Associated Macrovascular Complications: Cell-Based Therapy a New Tool? Endocrine, 44, 557-575. https://doi.org/10.1007/s12020-013-9936-8
|
[20]
|
Ezquer, F., Giraud-Billoud, M., Carpio, D., Cabezas, F., Conget, P., and Ezquer, M. (2015) Proregenerative Microenvironment Triggered by Donor Mesenchymal Stem Cells Preserves Renal Function and Structure in Mice with Severe Diabetes Mellitus. BioMed Re-search International, 2015, Article ID: 164703.
https://doi.org/10.1155/2015/164703
|
[21]
|
Kuroda, Y., Kitada, M., Wakao, S. and Dezawa, M (2011) Bone Mar-row Mesenchymal Cells: How Do They Contribute to Tissue Repair and Are They Really Stem Cells? Archivum Immu-nologiae et Therapiae Experimentalis, 59, Article No. 369. https://doi.org/10.1007/s00005-011-0139-9
|
[22]
|
Massee, M., Chinn, K., Lim, J.J., Godwin, L., Young, C.S. and Koob, T.J. (2016) Type I and II Diabetic Adipose-Derived Stem Cells Respond In Vitro to Dehydrated Human Amni-on/Chorion Membrane Allograft Treatment by Increasing Proliferation, Migration, and Altering Cytokine Secretion. Ad-vances in Wound Care, 5, 43-54.
https://doi.org/10.1089/wound.2015.0661
|
[23]
|
Yuan, Y.J., Shi, M.M., Li, L., Liu, J.P., Chen, B., Chen, Y.N., et al. (2016) Mesenchymal Stem Cell-Conditioned Media Ameliorate Diabetic Endothelial Dysfunction by Improving Mi-tochondrial Bioenergetics via the Sirt1/AMPK/PGC -1α Pathway. Clinical Science (London), 130, 2181-2198. https://doi.org/10.1042/CS20160235
|
[24]
|
Biancone, L., Bruno, S., Deregibus, M.C., Tetta, C. and Camussi, G. (2012) Therapeutic Potential of Mesenchymal Stem Cell-Derived Microvesicles. Nephrology Dialysis Transplantation, 27, 3037-3042.
https://doi.org/10.1093/ndt/gfs168
|
[25]
|
Gnecchi, M., Danieli, P., Malpasso, G. and Ciuffreda, M.C. (2016) Para-crine Mechanisms of Mesenchymal Stem Cells in Tissue Repair. In: Gnecchi, M., Ed., Mesenchymal Stem Cells, Vol. 1416, Humana Press, New York, 123-146.
https://doi.org/10.1007/978-1-4939-3584-0_7
|
[26]
|
Motazed, R., Colville-Nash, P., Kwan, J.T.C. and Dockrell, M.E.C. (2008) BMP-7 and Proximal Tubule Epithelial Cells: Activation of Multiple Signaling Pathways Reveals a Novel Anti-Fibrotic Mechanism. Pharmaceutical Research, 25, 2440-2446. https://doi.org/10.1007/s11095-008-9551-1
|
[27]
|
Luo, D.D., Phillips, A. and Fraser, D. (2010) Bone Morphoge-netic Protein-7 Inhibits Proximal Tubular Epithelial Cell Smad3 Signaling via Increased SnoN Expression. The American Journal of Pathology, 176, 1139-1147.
https://doi.org/10.2353/ajpath.2010.090459
|
[28]
|
Lv, S., Liu, G., Sun, A.L., Wang, J.P., Cheng, J., Wang, W.W., et al. (2014) Mesenchymal Stem Cells Ameliorate Diabetic Glomerular Fibrosis in Vivo and in Vitro by Inhibiting TGF-Beta Signalling via Secretion of Bone Morphogenetic Protein 7. Diabetes and Vascular Disease Research, 11, 251-261. https://doi.org/10.1177/1479164114531300
|
[29]
|
Lv, S.S., Liu, G., Wang, J.P., Wang, W.-W., Cheng, J., Sun, A.L., et al. (2013) Mesenchymal Stem Cells Transplantation Ameliorates Glomerular Injury in Streptozoto-cin-Induced Diabetic Nephropathy in Rats via Inhibiting Macrophage Infiltration. International Immunopharmacology, 17, 275-282. https://doi.org/10.1016/j.intimp.2013.05.031
|
[30]
|
Li, D.G., Wang, N., Zhang, L., Zhu, H.Y., Bai, X.Y., Bo, F., et al. (2013) Mesenchymal Stem Cells Protect Podocytes from Apoptosis Induced by High Glucose via Secretion of Epithelial Growth Factor. Stem Cell Research & Therapy, 4, Article No. 103. https://doi.org/10.1186/scrt314
|
[31]
|
张玮, 彭澎, 沈铿. 外泌体来源RNA在细胞通讯中的作用[J]. 中国医学科学院学报, 2016, 38(4): 480-483.
|
[32]
|
Bruno, S., Porta, S. and Bussolati, B. (2016) Extracellular Vesicles in Renal Tissue Damage and Regeneration. European Journal of Pharmacology, 790, 83-91. https://doi.org/10.1016/j.ejphar.2016.06.058
|
[33]
|
Jiang, Z.Z., Liu Y.-M., Niu, X., Yin, J.-Y., Hu, B., Guo, S.-C., et al. (2016) Exosomes Secreted by Human Urine-Derived Stem Cells Could Prevent Kidney Complications from Type I Diabetes in Rats. Stem Cell Research & Therapy, 7, Article No. 24. https://doi.org/10.1186/s13287-016-0287-2
|
[34]
|
Jin, J., Shi, Y.F., Gong, J.G., Zhao, L., Li, Y.W., He, Q. and Huang, H. (2019) Exosome Secreted from Adipose-Derived Stem Cells Attenuates Diabetic Nephropathy by Promoting Autophagy Flux and Inhibiting Apoptosis in Podocyte. Stem Cell Research & Therapy, 10, Article No. 95. https://doi.org/10.1186/s13287-019-1177-1
|
[35]
|
Nagaishi, K., Mizue, Y., Chikenji, T., Otani, M., Nakano, M., Konari, N., et al. (2016) Mesenchymal Stem Cell Therapy Ameliorates Diabetic Nephropathy via the Paracrine Effect of Renal Trophic Factors Including Exosomes. Scientific Reports, 6, Article No. 34842. https://doi.org/10.1038/srep34842
|
[36]
|
Ebrahim, N., Ahmed, I.A., Hussien, N.I., Dessouky, A.A., Farid, A.S., Elshazly, A.M., et al. (2018) Mesenchymal Stem Cell-Derived Exosomes Ameliorated Diabetic Nephropathy by Au-tophagy Induction through the mTOR Signaling Pathway. Cells, 7, 226. https://doi.org/10.3390/cells7120226
|
[37]
|
Wong, C.Y., Tan, E.L. and Cheong, S.K. (2014) In vitro Differentiation of Mesenchymal Stem Cells into Mesangial Cells When Co-Cultured with Injured Mesangial Cells. Cell Biology Interna-tional, 38, 497-501.
https://doi.org/10.1002/cbin.10231
|
[38]
|
Chamberlain, G., Fox, J., Ashton, B. and Middleton, J. (2007) Concise Review: Mesenchymal Stem Cells: Their Phenotype, Differentiation Capacity, Immunological Features, and Potential for Homing. Stem Cells, 25, 2739-2749.
https://doi.org/10.1634/stemcells.2007-0197
|
[39]
|
Cai, X.J., Wang, L., Wang, X.L., Hou, F. (2020) miR-124a En-hances Therapeutic Effects of Bone Marrow Stromal Cells Transplant on Diabetic Nephropathy-Related Epitheli-al-to-Mesenchymal Transition and Fibrosis. Journal of Cellular Biochemistry, 121, 299-312. https://doi.org/10.1002/jcb.29170
|
[40]
|
Duan, Y.R., Luo, Q.Y., Wang, Y., Ma, Y.L., Chen, F., Zhu, X.G., et al. (2020) Adipose Mesenchymal Stem Cell-Derived Extracellular Vesicles Containing MicroRNA-26a-5p Target TLR4 and Protect against Diabetic Nephropathy. Journal of Biological Chemistry, 295, 12868-12884.
|
[41]
|
Wang, S., Li, Y., Zhao, J.H., Zhang, J.B. and Huang, Y.J. (2013) Mesenchymal Stem Cells Ameliorate Podocyte Injury and Proteinuria in a Type 1 Diabetic Nephropathy Rat Model. Biol Blood Marrow Transplant, 19, 538-546.
https://doi.org/10.1016/j.bbmt.2013.01.001
|
[42]
|
Musial-Wysocka, A., Kot, M. and Majka, M. (2019) The Pros and Cons of Mesenchymal Stem Cell-Based Therapies. Cell Transplant, 28, 801-812. https://doi.org/10.1177/0963689719837897
|
[43]
|
Kunter, U., Rong, S., Boor, P., Eitner, F., Müller-Newen, G., Djuric, Z., et al. (2007) Mesenchymal Stem Cells Prevent Progressive Experimental Renal Failure but Maldifferentiate into Glomerular Adipocytes. Journal of the American Society of Nephrology, 18, 1754-1764. https://doi.org/10.1681/ASN.2007010044
|